Clinical Study of THSD7A, SOD2 and AR Antigens in Idiopathic Membranous Nephropathy

Background To explore the expression of THSD7A, SOD2 and AR podocyte antigens in the renal tissue of patients with idiopathic membranous nephropathy (IMN) and its clinical diagnostic value in IMN. Method This study retrospectively collected 150 renal tissue specimens and clinical data of patients undergoing renal biopsy in the Department of Nephrology, Shandong Provincial Hospital, including 130 IMN and 20 non-IMN patients. We use immunohistochemical staining to detect the expression of THSD7A, SOD2, AR antigens in the kidney tissue of patients. We focus on analyzing the clinical and pathological characteristics of IMN patients with positive THSD7A antigen expression, and analyze the prognosis of THSD7A-IMN patients and tumor occurrence. Meanwhile, the sensitivity and specificity of those antigens for the diagnosis of IMN were discussed. Results There were only 6 patients with THSD7A positive expression among 150 patients with glomerular disease, of which 5 patients were all IMN patients, and the patients' serum anti-PLA2R antibodies(anti-PLA2R-ab) were all negative. The positive rate of THSD7A in IMN was 3.85%, and the positive rate in IMN patients with anti-PLA2R-ab negative was 5.50%. Meanwhile, the sensitivity and specificity of renal tissue THSD7A in diagnosing IMN is 4.0% and 95%. In addition, the IgG subtype of THSD7A-IMN was mainly IgG4; Among them, 2 patients with IMN had both THSD7A and PLA2R antigen staining. This study also suggests that there is no significant difference in clinical and pathological characteristics between THSD7A positive and negative group. The follow-up of THSD7A-IMN patients found no tumors. This study also showed that there were 11 cases of anti-PLA2R-ab negative IMN patients with SOD2 antigen expression (8.56%), 10 cases of anti-PLA2R-ab negative and 4 cases of anti-PLA2R-ab positive IMN patients with AR antigen expression (10.77%), but no obvious SOD2 and AR antigen expression in SMN and other glomerular diseases. Conclusions Glomerular THSD7A antigen has a certain expression rate and high specificity in IMN, but its expression rate is low, and it can be used as a specific diagnostic index for IMN supplement. Kidney tissue SOD2, AR podocyte target antigens have a low positive rate in IMN, and further research is needed to evaluate the condition of IMN.

[1]  H. Debiec,et al.  Advances in Membranous Nephropathy , 2021, Journal of clinical medicine.

[2]  Aaron J. Storey,et al.  Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. , 2020, Kidney international.

[3]  F. Emma,et al.  Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. , 2020, Kidney international.

[4]  Yan Zhang,et al.  Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody , 2020, PeerJ.

[5]  M. Jadoul,et al.  Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. , 2020, Kidney international.

[6]  Yurong Qiu,et al.  Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy , 2019, International Urology and Nephrology.

[7]  U. Specks,et al.  Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. , 2019, Journal of the American Society of Nephrology : JASN.

[8]  Yan Zhang,et al.  THSD7A as a marker for paraneoplastic membranous nephropathy , 2019, International Urology and Nephrology.

[9]  Shree G. Sharma,et al.  Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study , 2017, Modern Pathology.

[10]  Ming-hui Zhao,et al.  Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[11]  L. Beck PLA2R and THSD7A: Disparate Paths to the Same Disease? , 2017, Journal of the American Society of Nephrology : JASN.

[12]  D. Salant,et al.  An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[13]  G. Remuzzi,et al.  Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy , 2015, PloS one.

[14]  H. Debiec,et al.  Pathophysiological advances in membranous nephropathy: time for a shift in patient's care , 2015, The Lancet.

[15]  J. Klein,et al.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.

[16]  M. Prunotto,et al.  Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. , 2011, Journal of proteomics.

[17]  克治 桑門 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[18]  M. Prunotto,et al.  Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. , 2010, Journal of the American Society of Nephrology : JASN.

[19]  M. Ivanova,et al.  Developmental expression and function of aldehyde reductase in proximal tubules of the kidney. , 2005, American journal of physiology. Renal physiology.

[20]  C. Nishimura,et al.  Localization of aldose and aldehyde reductase in the kidney. , 1989, Kidney international.

[21]  D. Hackel,et al.  The nephrotic syndrome in rats; with special reference to the progression of the glomerular lesion and to the use of nephrotoxic sera obtained from ducks. , 1952, The Journal of laboratory and clinical medicine.